C004
אקס טי אל ביופרמסוטיקלס בע"מ
2
Public
X T L BIOPHARMACEUTICALS LTD
4312
Corporation no:
520039470
Stock Exchange/Market:
אקס טי אל
1996
352
Hasapir
3
,
Nes Ziona
76100
,
,
Tel:
08-9304444
,
Fax:
08-9304445
E.mail address:
rcohen@xtlbio.com
Date of transmission:
22/05/2006
Time of broadcast:
19:38
16:54:23
Reference:
2006-02-065940
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate report on other matter
Don't use this form if there is more adequate one
XTL BIOPHARMACEUTICALS LTD. PUBLISHES PROSPECTUS FOR SECURITIES ISSUED PURSUANT TO THE PRIVATE PLACEMENT COMPLETED IN MARCH 2006
Attached file
07-06Publish_Prospectus_Announcement_22May06_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure:
30/03/2006
Name of the Signatory
:
Burgin Jonathan
,
,
Position of Signatory in the reporting corporation:
Chief Financial Officer
Hasapir
Telephone:
08-9304440
,
Facsimile:
08-9300659
,
E-mail:
jburgin@xtlbio.com